Cytovene

Active Ingredient(s): Ganciclovir
FDA Approved: * December 22, 1994
Pharm Company: * ROCHE PALO
Category: Antiviral

Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections. Ganciclovir was patented in 1980 and approved for medical use in 1988.[1] Contents 1 Medical use 2 Adverse effects 2.1 Toxicity 3 Mechanism of action 4 Pharmacokinetics 4.1 Administration 5 See also 6 References 7 Further reading 8 External links Medical use Ganciclovir is indicated for:[2] Sight-threatening CMV ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Related Brands

Drugs with the same active ingredients